Korean researchers develop biosensor to measure serotonin levels in real-time
A research team from the Korea Research Institute of Bioscience and Biotechnology has developed a biosensor that can track serotonin levels in real time for the diagnosis of depression.
Depression, which affects over a million South Koreans, is believed to be partly caused by imbalances in the level of neurotransmitters...
Lunit gets first go-ahead for South Korea IPO
AI startup Lunit has received preliminary approval from the Korea Exchange for its initial public offering on the KOSDAQ.
This comes five months after it raised $61 million in a fundraising event that was held to seek global partners.
In a recent statement, Lunit said it plans to file its registration statement within the first half of 2022 to...
Health tech companies raised $39.7 billion across 1,186 deals in 2021, more than double 2020's $18.1 billion, according to Silicon Valley Bank's Healthcare Investments and Exits report.
The hefty number from last year was four times higher than the average annual investment from 2018 and 2019, which clocked in at $11 billion. The report notes 60% of funding came from 105 "mega-rounds," deals...
Recently digital clinical documentation company Augmedix landed $40 million through a new IPO. The company, which is trading on Nasdaq under the symbol AUGX, offered a total of 10,000,000 shares of common stock at $4 per share.
According to the release, the underwriters had a 30-day option from the day the stock went public to purchase up to 1.5 million additional shares of common stock at the...
Waterdrop, a Chinese insurance technology firm, started trading at the New York Stock Exchange last week under the ticker WDH. In its initial public offering, the Tencent-backed firm raised $360 million, pricing shares at $12 apiece.
WHY IT MATTERS
Waterdrop was launched in 2016 through software developer Zongqing Xiangqian. It currently runs an insurance marketplace and a medical crowdfunding...
South Korean medical AI company made its debut on KOSDAQ, a trading board of Korea Exchange, for an IPO of 37.8 billion won ($33.6 million) by issuing 1.8 million shares.
WHY IT MATTERS
The company had accumulated an operating deficit of 7 billion won ($6.2 million) by the third quarter of 2020, and the funds will be a much needed injection of cash. Vuno plans to invest in research and...
NeuroPace, maker of an implanted neurostimulation therapy device for uncontrolled epileptic seizures, filed SEC documents yesterday outlining plans to raise as much as $75 million in an IPO listing on the Nasdaq.
The Mountain View, California-based company has been around since 1997 and has brought in a couple hundred million in funding across several rounds, according to CrunchBase. In fact, the...
No-cost medications for patients in need. Online prescription discount platform GoodRx has partnered with the National Association of Free and Charitable Clinics (NAFC) to kick off a philanthropic program that will support patients in need with free prescriptions and care.
With a target goal of more than $5 million in free medications provided during 2021, the company said that it has kick-...
Late Friday, New York City-based health insurance company Oscar Health unveiled plans to kick off an initial public offering.
The tech-enabled company will list on the New York Stock Exchange under the symbol OSCR. Oscar temporarily listed the size of the offering as $100 million, although that value could change as the company hammers out the quantity of shares and price range it will be...
Eargo hit the public market today with an initial public offering of about 7.9 million shares of common stock priced at $18 per share for estimated earnings of about $141.3 million.
This IPO is upsized from its original offering of about 6.7 million common stock shares priced between $14 and $16. Eargo has also granted the underwriters the option to purchase an additional 1.2 million shares at...
